Global Veterinary Diagnostics Market Professional Survey Report 2019

In this report, our team offers a comprehensive analysis of Veterinary Diagnostics market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain,market statistics in terms of revenue, sales, price, capacity, regional market analysis,segment-wise data,and market forecast information are offered in the full study, etc.This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
IDEXX Laboratories
Abaxis
Thermo Fisher Scientific
Heska
Zoetis
Bio-Rad Laboratories
IDvet
Shenzhen Mindray Bio-Medical Electronics
NEOGEN CORPORATION
QIAGEN
VCA
Virbac
...

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Immunodiagnostics
Molecular Diagnostics
Clinical Chemistry
Hematology Analyzers
Diagnostic Imagining

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Livestock
Companion Animals

By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2025 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Diagnostics Market, By Product

7.1.  Veterinary Diagnostics Market, By Product, 2020-2028

7.1.1.    Consumables, Reagents & Kits

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Instruments & Devices

7.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Veterinary Diagnostics Market, By Species

8.1.  Veterinary Diagnostics Market, By Species, 2020-2028

8.1.1.    Bovine

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Camelid

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Canine and Feline

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Caprine

8.1.4.1.        Market Revenue and Forecast (2016-2028)

8.1.5.    Equine

8.1.5.1.        Market Revenue and Forecast (2016-2028)

8.1.6.    Ovine

8.1.6.1.        Market Revenue and Forecast (2016-2028)

8.1.7.    Porcine

8.1.7.1.        Market Revenue and Forecast (2016-2028)

8.1.8.    Avian

8.1.8.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Veterinary Diagnostics Market, By Testing Category

9.1.  Veterinary Diagnostics Market, By Testing Category, 2020-2028

9.1.1.    Analytical Services

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Diagnostic Imaging

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Bacteriology

9.1.3.1.        Market Revenue and Forecast (2016-2028)

9.1.4.    Pathology

9.1.4.1.        Market Revenue and Forecast (2016-2028)

9.1.5.    Molecular Diagnostics

9.1.5.1.        Market Revenue and Forecast (2016-2028)

9.1.6.    Immunoassays

9.1.6.1.        Market Revenue and Forecast (2016-2028)

9.1.7.    Parasitology

9.1.7.1.        Market Revenue and Forecast (2016-2028)

9.1.8.    Serology

9.1.8.1.        Market Revenue and Forecast (2016-2028)

9.1.9.    Virology

9.1.9.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Veterinary Diagnostics Market, By Disease Type

10.1.        Veterinary Diagnostics Market, By Disease Type, 2020-2028

10.1.1.  Infectious Diseases

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Non-infectious Diseases

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  Hereditary, Congenital, and Acquired Diseases

10.1.3.1.      Market Revenue and Forecast (2016-2028)

10.1.4.  General Ailments

10.1.4.1.      Market Revenue and Forecast (2016-2028)

10.1.5.  Structural and Functional Diseases

10.1.5.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Veterinary Diagnostics Market, By End-Use

11.1.        Veterinary Diagnostics Market, By End-Use, 2020-2028

11.1.1.  Laboratories

11.1.1.1.      Market Revenue and Forecast (2016-2028)

11.1.2.  Veterinary Hospitals and Clinics

11.1.2.1.      Market Revenue and Forecast (2016-2028)

11.1.3.  Point-Of-Care/In-House Testing

11.1.3.1.      Market Revenue and Forecast (2016-2028)

11.1.4.  Research Institutes and Universities

11.1.4.1.      Market Revenue and Forecast (2016-2028)

Chapter 12.      Global Veterinary Diagnostics  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Product (2016-2028)

12.1.2.  Market Revenue and Forecast, By Species (2016-2028)

12.1.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.1.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.1.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.1.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.1.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.1.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Product (2016-2028)

12.2.2.  Market Revenue and Forecast, By Species (2016-2028)

12.2.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.2.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.2.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.2.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.2.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Product (2016-2028)

12.3.2.  Market Revenue and Forecast, By Species (2016-2028)

12.3.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.3.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.3.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.3.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.3.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Product (2016-2028)

12.4.2.  Market Revenue and Forecast, By Species (2016-2028)

12.4.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.8.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.8.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.8.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.8.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, By Product (2016-2028)

12.4.9.2.      Market Revenue and Forecast, By Species (2016-2028)

12.4.9.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.4.9.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.4.9.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Product (2016-2028)

12.5.2.  Market Revenue and Forecast, By Species (2016-2028)

12.5.3.  Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.4.  Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.5.  Market Revenue and Forecast, By End-Use (2016-2028)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.6.2.      Market Revenue and Forecast, By Species (2016-2028)

12.5.6.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.6.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.6.5.      Market Revenue and Forecast, By End-Use (2016-2028)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, By Product (2016-2028)

12.5.7.2.      Market Revenue and Forecast, By Species (2016-2028)

12.5.7.3.      Market Revenue and Forecast, By Testing Category (2016-2028)

12.5.7.4.      Market Revenue and Forecast, By Disease Type (2016-2028)

12.5.7.5.      Market Revenue and Forecast, By End-Use (2016-2028)

Chapter 13.  Company Profiles

13.1.              Abaxis, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              Idexx Laboratories, Inc.

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Heska Corporation

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Neogen Corp

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Merck

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Thermo Fisher Scientific, Inc

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              Qiagen N.V.

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Virbac Corp

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Zoetis, Inc.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           IDVet

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

13.11.           Agrolabo SPA

13.11.1.               Company Overview

13.11.2.               Product Offerings

13.11.3.               Financial Performance

13.11.4.               Recent Initiatives

13.12.           Im3 Inc.

13.12.1.               Company Overview

13.12.2.               Product Offerings

13.12.3.               Financial Performance

13.12.4.               Recent Initiatives

13.13.           VCA Antech

13.13.1.               Company Overview

13.13.2.               Product Offerings

13.13.3.               Financial Performance

13.13.4.               Recent Initiatives

13.14.           Henry Schein, Inc.

13.14.1.               Company Overview

13.14.2.               Product Offerings

13.14.3.               Financial Performance

13.14.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers